- Home
- EXEL vs DOX Comparison
EXEL vs DOX Comparison
Compare EXEL & DOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- DOX
- Stock Information
- Founded
- EXEL 1994
- DOX 1982
- Country
- EXEL United States
- DOX United States
- Employees
- EXEL N/A
- DOX N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- DOX EDP Services
- Sector
- EXEL Health Care
- DOX Technology
- Exchange
- EXEL Nasdaq
- DOX Nasdaq
- Market Cap
- EXEL 9.8B
- DOX 9.9B
- IPO Year
- EXEL 2000
- DOX 1998
- Fundamental
- Price
- EXEL $43.04
- DOX $91.76
- Analyst Decision
- EXEL Buy
- DOX Strong Buy
- Analyst Count
- EXEL 18
- DOX 3
- Target Price
- EXEL $38.76
- DOX $105.33
- AVG Volume (30 Days)
- EXEL 3.9M
- DOX 600.2K
- Earning Date
- EXEL 05-13-2025
- DOX 05-07-2025
- Dividend Yield
- EXEL N/A
- DOX 2.30%
- EPS Growth
- EXEL 237.58
- DOX 6.36
- EPS
- EXEL 2.20
- DOX 4.74
- Revenue
- EXEL $2,298,922,000.00
- DOX $4,752,199,000.00
- Revenue This Year
- EXEL $10.39
- DOX N/A
- Revenue Next Year
- EXEL $10.74
- DOX $4.26
- P/E Ratio
- EXEL $19.53
- DOX $19.36
- Revenue Growth
- EXEL 24.49
- DOX N/A
- 52 Week Low
- EXEL $20.40
- DOX $74.41
- 52 Week High
- EXEL $48.85
- DOX $94.61
- Technical
- Relative Strength Index (RSI)
- EXEL 59.93
- DOX 57.79
- Support Level
- EXEL $42.21
- DOX $90.40
- Resistance Level
- EXEL $43.75
- DOX $92.83
- Average True Range (ATR)
- EXEL 1.60
- DOX 1.43
- MACD
- EXEL -0.09
- DOX -0.08
- Stochastic Oscillator
- EXEL 53.96
- DOX 54.55
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About DOX Amdocs Limited
Amdocs Ltd is a provider of software and services to communications, cable and satellite, entertainment, and media industry service providers. The Company and its subsidiaries operate in one operating segment, providing software products and services for the communications, entertainment and media industry service being designed, develop, market, support, implement, and operate its open and modular cloud offering. The company offers business support systems, operational support systems, and managed services. Geographically, it derives a majority of revenue from North America and also has a presence in Europe and the Rest of the world.